Prognostic Impact of Immune Microenvironment in Lung Squamous Cell Carcinoma: Tumor-Infiltrating CD10+ Neutrophil/CD20+ Lymphocyte Ratio As an Independent Prognostic Factor

Overview

Journal J Thorac Oncol

Publisher Elsevier

Specialties Oncology
Pulmonary Medicine

Date 2015 Aug 21

PMID 26291010

Citations 32

Authors

Kyuichi Kadota

Jun-Ichi Nitadori

Hideki Ujiie

Daniel H Buitrago

Kaitlin M Woo

Camelia S Sima

William D Travis

David R Jones

Prasad S Adusumilli

Affiliations

Soon will be listed here.

Abstract

Introduction: We previously reported the prognostic significance of the lung adenocarcinoma immune microenvironment. In this study, we preformed comprehensive analysis of immune markers and their associations with prognosis in patients with lung squamous cell carcinoma.

Methods: We reviewed surgically resected, solitary lung squamous cell carcinoma patients (n = 485; 1999-2009) who were randomly split into a training cohort (n = 331) and validation cohort (n = 154). We constructed tissue microarrays and performed immunostaining for CD3, CD45RO, CD8, CD4, FoxP3, CD20, CD68, CXCL12, CXCR4, CCR7, interleukin-7 receptor, and interleukin-12 receptor β2. Overall survival (OS) was analyzed using the log-rank test and the Cox proportional hazards model.

Results: Analysis of single immune cell infiltration revealed that high tumor-infiltrating CD10(+) neutrophils were associated with worse prognoses in the training cohort (p = 0.021). Analysis of biologically relevant immune cell combinations identified that patients with high CD10 neutrophil and low CD20(+) lymphocyte had a significantly worse OS (5-year OS, 42%) than those with other combinations of CD10 and CD20 (5-year OS, 62%; p < 0.001); this was confirmed in the validation cohort (p = 0.032). For the multivariate analysis, high CD10/low CD20 immune cell infiltration was an independent predictor of OS in both the training cohort (hazard ratio = 1.61, p = 0.006) and the validation cohort (hazard ratio = 1.75; p = 0.043).

Conclusion: High CD10(+)/low CD20(+) immune cell infiltration ratio is a significant prognostic factor of lung squamous cell carcinoma. Immunomodulatory therapy of tumor-specific neutrophil and B-lymphocyte responses may have applicability in the treatment of lung squamous cell carcinoma.

Citing Articles

Do The Inflammatory Cells In The Blood And Tissues Have Predictive And Prognostic Value In Benign, Premalignant And Malignant Lesions Of The Larynx?.

Gokgun O, Gencay S, Durgut O, Solmaz F, Mutlu N Indian J Otolaryngol Head Neck Surg. 2025; 77(1):143-148.

PMID: 40066404 PMC: 11890454. DOI: 10.1007/s12070-024-05127-3.

Prediction of STAS in lung adenocarcinoma with nodules ≤ 2 cm using machine learning: a multicenter retrospective study.

Zhang Z, Zhao Y, Ma Y, Chen C, Li Z, Wang Y BMC Cancer. 2025; 25(1):417.

PMID: 40055661 PMC: 11887330. DOI: 10.1186/s12885-025-13783-z.

Identification of potential biomarkers for lung cancer using integrated bioinformatics and machine learning approaches.

Rabby M, Islam M, Kumar S, Maniruzzaman M, Hasan M, Tomioka Y PLoS One. 2025; 20(2):e0317296.

PMID: 40014586 PMC: 11867339. DOI: 10.1371/journal.pone.0317296.

Prognostic implications of tumor-infiltrating lymphocytes in non-small cell lung cancer: a systematic review and meta-analysis.

Yan Q, Li S, He L, Chen N Front Immunol. 2024; 15:1476365.

PMID: 39372398 PMC: 11449740. DOI: 10.3389/fimmu.2024.1476365.

Immunomodulatory role of tumor microenvironment on oncological outcomes in advanced laryngeal cancer.

Rzepakowska A, Oledzka J, Daniel P, Mekarska M, Zurek M, Kulbaka K BMC Cancer. 2024; 24(1):1219.

PMID: 39354397 PMC: 11446085. DOI: 10.1186/s12885-024-12959-3.

References

Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, Komuta K . Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer. 2009; 45(11):1950-8. DOI: 10.1016/j.ejca.2009.01.023. View

Dignam J, Zhang Q, Kocherginsky M . The use and interpretation of competing risks regression models. Clin Cancer Res. 2012; 18(8):2301-8. PMC: 3328633. DOI: 10.1158/1078-0432.CCR-11-2097. View

Wu Q, Wang J, Condron C, Bouchier-Hayes D, Redmond H . Human neutrophils facilitate tumor cell transendothelial migration. Am J Physiol Cell Physiol. 2001; 280(4):C814-22. DOI: 10.1152/ajpcell.2001.280.4.C814. View

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29. DOI: 10.3322/caac.20138. View

Lee M, Buitrago D, Kadota K, Ujiie H, Woo K, Sima C . The tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer. Oncoimmunology. 2015; 3(11):e967142. PMC: 4368147. DOI: 10.4161/21624011.2014.967142. View

Sarraf K, Belcher E, Raevsky E, Nicholson A, Goldstraw P, Lim E . Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009; 137(2):425-8. DOI: 10.1016/j.jtcvs.2008.05.046. View

Chappell R . Competing risk analyses: how are they different and why should you care?. Clin Cancer Res. 2012; 18(8):2127-9. DOI: 10.1158/1078-0432.CCR-12-0455. View

Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R . Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005; 353(25):2654-66. DOI: 10.1056/NEJMoa051424. View

Fridlender Z, Sun J, Kim S, Kapoor V, Cheng G, Ling L . Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell. 2009; 16(3):183-94. PMC: 2754404. DOI: 10.1016/j.ccr.2009.06.017. View

10.

Nozawa H, Chiu C, Hanahan D . Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci U S A. 2006; 103(33):12493-8. PMC: 1531646. DOI: 10.1073/pnas.0601807103. View

11.

Kadota K, Villena-Vargas J, Nitadori J, Sima C, Jones D, Travis W . Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma. Ann Surg Oncol. 2015; 22(9):3136-43. PMC: 4511716. DOI: 10.1245/s10434-015-4374-x. View

12.

Suzuki K, Kadota K, Sima C, Nitadori J, Rusch V, Travis W . Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence. J Clin Oncol. 2012; 31(4):490-8. PMC: 3731922. DOI: 10.1200/JCO.2012.45.2052. View

13.

Mano Y, Shirabe K, Yamashita Y, Harimoto N, Tsujita E, Takeishi K . Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 2013; 258(2):301-5. DOI: 10.1097/SLA.0b013e318297ad6b. View

14.

Trellakis S, Bruderek K, Dumitru C, Gholaman H, Gu X, Bankfalvi A . Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer. 2010; 129(9):2183-93. DOI: 10.1002/ijc.25892. View

15.

Eruslanov E, Bhojnagarwala P, Quatromoni J, Stephen T, Ranganathan A, Deshpande C . Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest. 2014; 124(12):5466-80. PMC: 4348966. DOI: 10.1172/JCI77053. View

16.

Horne Z, Jack R, Gray Z, Siegfried J, Wilson D, Yousem S . Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer. J Surg Res. 2011; 171(1):1-5. DOI: 10.1016/j.jss.2011.03.068. View

17.

Goldstraw P, Crowley J, Chansky K, Giroux D, Groome P, Rami-Porta R . The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007; 2(8):706-14. DOI: 10.1097/JTO.0b013e31812f3c1a. View

18.

Yoshizawa A, Fukuoka J, Shimizu S, Shilo K, Franks T, Hewitt S . Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer. Clin Cancer Res. 2009; 16(1):240-8. PMC: 7581274. DOI: 10.1158/1078-0432.CCR-09-0986. View

19.

Gondo T, Nakashima J, Ohno Y, Choichiro O, Horiguchi Y, Namiki K . Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology. 2012; 79(5):1085-91. DOI: 10.1016/j.urology.2011.11.070. View

20.

Zhang L, Conejo-Garcia J, Katsaros D, Gimotty P, Massobrio M, Regnani G . Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med. 2003; 348(3):203-13. DOI: 10.1056/NEJMoa020177. View